Source: Eur Respir J 2001; 18: 93S-100S



Rating:

Share or cite this content

Citations should be made in the following way:
Camus Ph., Foucher P., Bonniaud Ph., Ask K.. Drug-induced infiltrative lung disease. Eur Respir J 2001; 18: 93S-100S

Member's Comments

No comment yet.

Related content which might interest you: Drug-induced lung disease Source: Respipedia Article Year: 2017 A case series study on re-treatment to lung cancer after drug-induced interstitial lung disease Source: International Congress 2018 – CTD-ILD and hypersensitivity pneumonitis: from the bench to the bedside Year: 2018 A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Desquamative interstitial pneumonia: an analytic review with an emphasis on aetiology Source: Eur Respir Rev 2013; 22: 117-123 Year: 2013 Contemporary surgical issues in NSCLC treatment Source: Annual Congress 2007 - PG7 - Thoracic oncology: nonsmall cell lung cancer Year: 2007 Comparison of registries of interstitial lung diseases in three European countries Source: Eur Respir J 2001; 18: 114S-118S Year: 2001 Stratified medicine: drugs meet genetics Source: Eur Respir Rev 2013; 22: 53-57 Year: 2013 Statin-induced infiltrative lung disease. A series of 10 patients Source: Eur Respir J 2007; 30: Suppl. 51, 118s Year: 2007 Drug-induced ILD Source: Annual Congress 2007 - PG5 - Interstitial lung diseases: known causes and systemic disorders Year: 2007 Osteoporosis and inflammation Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Morphologic evaluation of lung in a scleroderma-like rabbit model Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease Year: 2006 Interstital lung diseases: update 2005 Source: Annual Congress 2005 - Clinical year in review Year: 2005 Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon Source: Eur Respir J 2012; 39: 669-676 Year: 2012 Interstitial lung disease Source: Eur Respir Rev 2013; 22: 26-32 Year: 2013 Acute lung injury as a possible adverse drug reaction related to gefitinib Source: Eur Respir J 2002 Jan 01;22(1):179-181 Year: 2003 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 Pivotal role of the HMGB1/sRAGE axis in drug-induced lung injury in advanced lung cancer with pre-existing interstitial lung disease Source: Virtual Congress 2020 – Addressing unresolved questions in rare diffuse parenchymal lung diseases: interdisciplinary research is the key Year: 2020 A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC) Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013